Ke Wang
8PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 02, 2026
Inducible CD147 up-regulation boosts extended SARS-CoV-2 infection triggering severe COVID-19 independent of ACE2.Ke Wang, Peng Lin, Ruo Chen
|Jan 10, 2025
Lower respiratory tract microbiome dysbiosis impairs clinical responses to immune checkpoint blockade in advanced non-small-cell lung cancer.Yong Zhang, Xiang-Xiang Chen, Ruo Chen
|Jun 14, 2024
CD147-K148me2-Driven Tumor Cell-Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis.Ke Wang, Xiaohong Chen, Peng Lin
|Feb 24, 2024
<i>Dclre1c</i>-Mutation-Induced Immunocompromised Mice Are a Novel Model for Human Xenograft Research.Yixiao Bin, Sanhua Wei, Ruo Chen
|Feb 03, 2023
Metabolic interaction: tumor-derived lactate inhibiting CD8<sup>+</sup> T cell cytotoxicity in a novel route.Ke Wang, Yong Zhang, Zhi-Nan Chen
|Jan 30, 2023
Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial.Huijie Bian, Liang Chen, Zhao-Hui Zheng
Pageof 2
Frequent Collaborators
4 joint publications
Huijie Bian
3 joint publications
Chuan Qin
2 joint publications
Youchun Wang
1 joint publications
Jing Yuan
1 joint publications
Nosheen Nasir
1 joint publications
Sanhua Wei
1 joint publications
Hai Zhang
1 joint publications
Qiang Huang
1 joint publications
Lei Zhang
1 joint publications
Linlin Bao
